Skip to main content

Cholecystectomy

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Distalmotion
DistalmotionSwitzerland - Epalinges
1 program
CholecystectomyN/A1 trial
Active Trials
NCT06473688Completed51Est. Dec 2024
Intuitive Surgical
Intuitive SurgicalCA - Sunnyvale
1 program
Regular HoursN/A1 trial
Active Trials
NCT04551820Completed520Est. Sep 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
DistalmotionCholecystectomy
Intuitive SurgicalRegular Hours

Clinical Trials (2)

Total enrollment: 571 patients across 2 trials

The DEXTER-assisted Non-Emergent and Acute cholecyStecTomy Study (The NEST Study)

Start: Jun 2024Est. completion: Dec 202451 patients
N/ACompleted

Study of Peri-operative and Acute Outcomes After Robotic-assisted Cholecystectomy

Start: Aug 2020Est. completion: Sep 2021520 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.